# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
UBS analyst Andrea Alfonso maintains Elanco Animal Health (NYSE:ELAN) with a Buy and raises the price target from $19 to $25.
JP Morgan analyst Chris Schott upgrades Elanco Animal Health (NYSE:ELAN) from Neutral to Overweight and raises the price tar...
Stifel analyst Jonathan Block maintains Elanco Animal Health (NYSE:ELAN) with a Buy and raises the price target from $18 to ...
FDA now concludes "the totality of evidence supports removal of the risk of fatal vaccine-induced disease from modified liv...
Elanco Animal Health Incorporated (NYSE:ELAN) has announced significant advancements with its two most recent pet health innova...